Study details
Enrolling now
Convalescent Plasma Collection and Treatment
West Virginia University
NCT IDNCT04376034ClinicalTrials.gov data as of Apr 2026
Phase
Phase 3
Target enrollment
240
Study length
about 12 months
Ages
0.0848751172166437+
Locations
1 site in WV
What this study is about
Researchers are testing whether convalescent plasma can help people recover from COVID-19. Participants will receive either one or two units of plasma, or standard care. The trial will last for 348 days.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive Convalescent Plasma 1 Unit
- 2.Receive Convalescent Plasma 2 Units
- 3.Standard of Care
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Body systems
Infectious